Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Aluminium adjuvants, typically referred to as 'alum', are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by alum remains unknown. Toll-like receptors are critical in sensing infections and are therefore common targets of various adjuvants used in immunological studies. Although alum is known to induce the production of proinflammatory cytokines in vitro, it has been repeatedly demonstrated that alum does not require intact Toll-like receptor signalling to activate the immune system. Here we show that aluminium adjuvants activate an intracellular innate immune response system called the Nalp3 (also known as cryopyrin, CIAS1 or NLRP3) inflammasome. Production of the pro-inflammatory cytokines interleukin-1beta and interleukin-18 by macrophages in response to alum in vitro required intact inflammasome signalling. Furthermore, in vivo, mice deficient in Nalp3, ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) or caspase-1 failed to mount a significant antibody response to an antigen administered with aluminium adjuvants, whereas the response to complete Freund's adjuvant remained intact. We identify the Nalp3 inflammasome as a crucial element in the adjuvant effect of aluminium adjuvants; in addition, we show that the innate inflammasome pathway can direct a humoral adaptive immune response. This is likely to affect how we design effective, but safe, adjuvants in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Cited by
Items 901–1,000 of 1,002
Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice
Sunay, M. M. E., Martins, K. A. O., Steffens, J. T., Gregory, M. K., Tongeren, S. A. V., Hoeven, N. V., Garnes, P. G., & Bavari, S. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.05.026 · Cited by 21
DiStefano, D. J., Antonello, J. M., Bett, A. J., Medi, M. B., Casimiro, D. R., & ter Meulen, J. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.034 · Cited by 21
The Inflammasome in Host Defense
Chen, G., & Pedra, J. H. F. (2009) · Sensors · doi:10.3390/s100100097 · Cited by 37
“, malarial hemozoin, crystal structures and fungal toxins, viral RNA, among others [8,51-68].”
BackgroundScheiblhofer, S., Machado, Y. J., Feinle, A., Thalhamer, J., Hüsing, N., & Weiss, R. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1203898 · Cited by 22
“leads to activation of the Nalp3 inflammasome, and, in the long run, to production of pro-inflammatory cytokines and strong antibody responses [31,32].”
BackgroundXu, F., Ji, Q., Zhang, J., Huang, W., Cao, Z., & Li, Y. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.06.171 · Cited by 20
Li, M., Shi, H., Mu, Y., Luo, Z., Zhang, H., Wan, Y., Zhang, D., Lu, L., Men, K., Tian, Y., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-179 · Cited by 20
“Several studies have demonstrated that alum triggers lysosomal membrane damage with subsequent activation of the Nlrp3 inflammasome for its adjuvanticity [39,40].”
BackgroundThe Nlrp3 Inflammasome Does Not Regulate Alloimmunization to Transfused Red Blood Cells in Mice
Gibb, D. R., Calabrό, S., Liu, D., Tormey, C. A., Spitalnik, S. L., Zimring, J. C., Hendrickson, J. E., Hod, E. A., & Eisenbarth, S. C. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.008 · Cited by 20
“3d) (Mariathasan et al., 2006; Eisenbarth et al., 2008; Li et al., 2008).”
Self-citationDuffy, E. B., Periasamy, S., Hunt, D., Drake, J. R., & Harton, J. A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2a1215-555rr · Cited by 20
“The importance of the inflammasome and the IL-1 response for promoting adaptive immunity and subsequent Ab production [5, 43, 44, 50, 51] led us to consider whether iFt-mAb complexes elicit an inflammasome-dependent IL-1b response.”
BackgroundPreclinical Toxicology of Vaccines
Green, M. D., & Al-Humadi, N. H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387815-1.00025-3 · Cited by 20
“10 For some vaccines and drugs targeting neurological diseases, such direct nose-to-brain transport may be advantageous but raises concerns about potential adverse effects when the brain is not the target organ.”
BackgroundDeveloping food allergy: a potential immunologic pathway linking skin barrier to gut
Wang, Y. (2016) · F1000Research · doi:10.12688/f1000research.9497.1 · Cited by 26
Khong, H., Volmari, A., Sharma, M., Dai, Z., Imo, C. S., Hailemichael, Y., Singh, M., Moore, D. T., Xiao, Z., Huang, X.-F., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700467 · Cited by 21
“Indeed, alum was shown to activate the NALP3 inflammasome in DC (23).”
BackgroundUric acid and the vaccine adjuvant activity of aluminium (oxy)hydroxide nanoparticles
Thakkar, S. G., Xu, H., Li, X., & Cui, Z. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1428808 · Cited by 20
Role of Damage-Associated Molecular Pattern/Cell Death Pathways in Vaccine-Induced Immunity
Lee, S. M., Kim, P., You, J., & Kim, E. H. (2021) · Viruses · doi:10.3390/v13122340 · Cited by 24
“In contrast to the common mechanism of action of several adjuvants that trigger TLR signaling transduction, alum salts are known to require NLRP3 inflammasome activation for the production of pro-inflammatory cytokines [71].”
BackgroundGuo, Y., Gu, D., Huang, T., Li, A., Zhou, Y., Kang, X., Meng, C., Xiong, D., Song, L., Jiao, X., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011381 · Cited by 20
“Notably, the NLRP3 inflammasome was identified as a crucial element to trigger T cell responses in the adjuvant effect of aluminum adjuvants for human vaccines, whereas innate inflammasome signals could direct a humoral adaptive immune response [52].”
BackgroundLee, K.-G., Hong, B., Lee, S., Lee, N., Kim, S., Kim, D.-H., & Kim, W. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01121-x · Cited by 22
Novel paradigms of innate immune sensing of viral infections
Hare, D. N., & Mossman, K. L. (2013) · Cytokine · doi:10.1016/j.cyto.2013.06.001 · Cited by 25
Inflammatory and Autoimmune Reactions in Atherosclerosis and Vaccine Design Informatics
Jan, M., Meng, S., Chen, N. C., Mai, J., Wang, H., & Yang, X. (2010) · BioMed Research International · doi:10.1155/2010/459798 · Cited by 22
“One member of an intracellular PRR, the NALP3 inflammasome, is activated by a number of classical adjuvants including aluminum hydroxide and saponins [34, 35].”
BackgroundThe Canonical Inflammasome: A Macromolecular Complex Driving Inflammation
Monie, T. P. (2017) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-319-46503-6_2 · Cited by 21
Tian, Y., Li, M., Yu, C., Zhang, R., Zhang, X., Huang, R., Lu, L., Yuan, F., Fan, Y., Zhou, B., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17504 · Cited by 19
“Recent studies have gradually revealed that alum activates the NALP3 inflammasome followed by the release of IL-1β, IL-18, IL-33, and induces a Th2-biased immune response [10, 11].”
BackgroundThe avian influenza vaccine Emerflu. Why did it fail?
Young, B. E., Sadarangani, S. P., & Leo, Y. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1059760 · Cited by 19
“Many of these responses appear to be mediated via activation of the NLRP inflammasome complex, which results in release of pro-inflammatory cytokines such as IL-1b, IL-18 and IL-33 [44,45].”
BackgroundJoshi, S. R., Shaw, A. C., & Quagliarello, V. (2009) · PubMed Central · Cited by 19
Yakabe, K., Uchiyama, J., Akiyama, M., & Kim, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020163 · Cited by 18
Patil, S. M., Manu, G., Shivachandra, J. C., Kumar, K. M. A., Vigneswaran, J., Ramu, R., Shirahatti, P. S., & Ranganatha, V. L. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100056 · Cited by 18
The effects of NOD-like receptors on adaptive immune responses
Tsankov, B. K., Luchak, A., Carr, C., & Philpott, D. J. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.100637 · Cited by 19
“Initial studies regarding the role of NLRP3 in CD4 + T cell function indicated myeloid-expressed NLRP3 is crucial for effective CD4 + cytokine [78] and proliferative [79] responses during T cell priming using model OVA antigen.”
BackgroundPrzysiecki, C. T., Lucas, B. J., Mitchell, R. A., Carapau, D., Wen, Z., Xu, H., Wang, X.-M., Nahas, D. D., Wu, C., Hepler, R. W., et al. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00146 · Cited by 18
“Adsorption of the peptide conjugates to alum adjuvant may further increase the immunogenicity of the OMPC based conjugates, by stimulating innate immune responses through NLRP3 inflammasome (Eisenbarth et al., 2008; Li et al., 2008).”
Thomas, B., Nishikawa, S. G., Ito, K., Chopra, P., Sharma, N., Evans, D. H., Tyrrell, D. L., Bathe, O. F., & Rancourt, D. E. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.12.070 · Cited by 18
Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease
Martins, R. D. C., Irache, J. M., & Gamazo, C. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.172 · Cited by 18
Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Sjögren's Syndrome.
Colafrancesco, S., Perricone, C., & Shoenfeld, Y. (2016) · PubMed · Cited by 18
Evolution of adjuvants across the centuries
Garçon, N., Hem, S. L., & Friede, M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00020-3 · Cited by 20
Huh, J.-W., Lee, J., Jeon, E., Ryu, H. W., Oh, S., Ahn, K., Jun, H. S., & Ha, U. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12899 · Cited by 19
Reithofer, M., Karacs, J., Strobl, J., Kitzmüller, C., Polak, D., Seif, K., Kamalov, M., Becker, C. F. W., Greiner, G., Schmetterer, K. G., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001413r · Cited by 19
Vaccine Nanoparticles Derived from Mung Beans for Cancer Immunotherapy
Wang, N., Zhang, G., Sun, H., Tian, Y., Hao, J., & Cui, J. (2021) · Chemistry of Materials · doi:10.1021/acs.chemmater.1c00629 · Cited by 18
Current Prospects in Peptide-Based Subunit Nanovaccines
Koirala, P., Bashiri, S., Tóth, I., & Skwarczyński, M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1892-9_16 · Cited by 18
Microbial Sensing by the Intestinal Epithelium in the Pathogenesis of Inflammatory Bowel Disease
Scharl, M. M., & Rogler, G. (2010) · International Journal of Inflammation · doi:10.4061/2010/671258 · Cited by 20
“Among the activators of NALP3 are vaccine adjuvants, such as alum [87–90], bacteria, such as Listeria monocytogenes [91, 92] and MDP.”
BackgroundRecent Developments in Immune Activation by Uric Acid Crystals
Ng, G., Chau, E. M. T., & Shi, Y. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0082-1 · Cited by 18
“Coincidentally, alum, a human adjuvant, is also known to activate the NLRP3 inflammasome and induce upregulation of costimulatory molecules and other activation markers on professional APCs (Eisenbarth et al. 2008; Marrack et al. 2009; Ulanova et al. 2001).”
BackgroundProtein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation
Yang, Y., Inatsuka, C., Gad, E. A., Disis, M. L., Standish, L. J., Pugh, N. D., Pasco, D. S., & Lu, H. (2013) · Innate Immunity · doi:10.1177/1753425913513814 · Cited by 20
“Inflammasome activation has also been shown to play an important role in the adjuvant activity of aluminum, the most commonly used vaccine adjuvant.(5,6) A recent publication has shown that PSK stimulates the proliferation of Ag-specific T-cells when used as an adjuvant to ova peptide vaccine.”
Awate, S., Eng, N. F., Gerdts, V., Babiuk, L. A., & Mutwiri, G. (2014) · Vaccines · doi:10.3390/vaccines2030500 · Cited by 18
Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
Milicic, A., Rollier, C. S., Tang, C. K., Longley, R. J., Hill, A. V. S., & Reyes‐Sandoval, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-07246-0 · Cited by 19
Adjuvant pretreatment with alum protects neonatal mice in sepsis through myeloid cell activation
Rincon, J. C., Cuenca, A. L., Raymond, S. L., Mathias, B. J., Nacionales, D. C., Ungaro, R. F., Efron, P. A., Wynn, J. L., Moldawer, L. L., & Larson, S. D. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.13072 · Cited by 18
Mishra, K. P., Chanda, S., Shukla, K., & Ganju, L. (2009) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903218874 · Cited by 18
“The enhanced antibody response may also involve NOD like receptor pathway (Nalp3) which has recently been explored for the alum’s adjuvanticity as one of the mechanisms for enhancing antigen specific antibody response [21].”
BackgroundDoepker, L. E., White, J., Cambier, J. C., Kappler, J. W., & Marrack, P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501565 · Cited by 17
Marunouchi, T., Iguchi, A., Shindo, A., Shimbo, N., Yano, E., & Tanonaka, K. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115547 · Cited by 17
HSP90β controls NLRP3 autoactivation
Spel, L., Hou, C., Theodoropoulou, K., Zaffalon, L., Wang, Z., Bertoni, A., Volpi, S., Hofer, M., Gattorno, M., & Martinon, F. (2024) · Science Advances · doi:10.1126/sciadv.adj6289 · Cited by 17
Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications
Aryan, Z., Comapalati, E., Canonica, G. W., & Rezaei, N. (2013) · Expert Review of Vaccines · doi:10.1586/erv.13.45 · Cited by 18
Highlights of the advances in basic immunology in 2011
Liu, J., Liu, S., & Cao, X. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2012.12 · Cited by 19
Xu, H., Ruwona, T. B., Thakkar, S. G., Chen, Y., Zeng, M., & Cui, Z. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1365995 · Cited by 18
Lindblad, E. B., & Duroux, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804019-5.00018-9 · Cited by 24
Conjugation of a Small-Molecule TLR7 Agonist to Silica Nanoshells Enhances Adjuvant Activity
Huang, C., Mendez, N., Echeagaray, O., Weeks, J. L., Wang, J., Vallez, C. N., Gude, N. A., Trogler, W. C., Carson, D. A., Hayashi, T., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b08295 · Cited by 17
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination
Theobald, S. J., Simonis, A., Mudler, J. M., Göbel, U., Acton, R., Kohlhas, V., Albert, M., Hellmann, A., Malin, J. J., Winter, S., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202215888 · Cited by 19
“Activated GSDMD forms membrane pores causing pyroptosis, a highly pro-inflammatory form of necrotic cell death (Mariathasan et al , 2006; Eisenbarth et al , 2008; Lamkanfi & Dixit, 2014; Broz & Dixit, 2016; Swanson et al , 2019).”
BackgroundAluminum as a CNS and Immune System Toxin Across the Life Span
Shaw, C. A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1370-7_4 · Cited by 19
NLRs and the dangers of pollution and aging
Willingham, S. B., & Ting, J. P. ‐. (2008) · Nature Immunology · doi:10.1038/ni0808-831 · Cited by 18
Advances of Nanotechnology Toward Vaccine Development Against Animal Infectious Diseases
Wang, X., Gao, X., Wang, L., Lin, J., & Liu, Y. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202305061 · Cited by 19
Yamaguchi, M., Mtali, Y. S., Sonokawa, H., Takashima, K., Fukushima, Y., Kouwaki, T., & Oshiumi, H. (2023) · Microbiology and Immunology · doi:10.1111/1348-0421.13108 · Cited by 16
“12,13 In fl ammasomes activate Caspase ‐ 1, which cleaves pro ‐ IL ‐ 1 β to produce mature IL ‐ 1 β proteins.”
BackgroundFavoino, E., Favia, E. I., Digiglio, L., Racanelli, V., Shoenfeld, Y., & Perosa, F. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12208 · Cited by 16
Hypoparathyroidism and Pseudohypoparathyroidism
Thakker, R. V. (2012) · Springer eBooks · doi:10.1007/978-1-4419-5550-0_14 · Cited by 16
Nod-like receptors in head and neck squamous cell carcinoma
Millrud, C. R., Kvarnhammar, A. M., Tajti, J., Munck‐Wikland, E., Uddman, R., & Cardell, L. (2013) · Acta Oto-Laryngologica · doi:10.3109/00016489.2013.831476 · Cited by 16
“Nlrp3 recognizes microbial products and danger signals, and it has been shown to respond to aluminium adjuvants, used in many vaccines [6].”
BackgroundEvaluation of pyroptosis in macrophages using cytosolic delivery of purified flagellin
Lage, S. L., Amarante-Mendes, G. P., & Bortoluci, K. R. (2013) · Methods · doi:10.1016/j.ymeth.2013.02.010 · Cited by 18
Vasseur, F., Sendid, B., Broly, F., Gower‐Rousseau, C., Sarazin, A., Standaert‐Vitse, A., Colombel, J., Poulain, D., & Jouault, T. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-35 · Cited by 17
“However, there are now strong evidences that it has a significant role in modulating the adaptive immune response [26,27].”
BackgroundGreen, M. D., & Al-Humadi, N. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803620-4.00027-x · Cited by 21
Childers, G. M., Perry, C. A., Blachut, B., Martin, N. P., Bortner, C. D., Sieber, S. O., Li, J., Fessler, M. B., & Harry, G. J. (2021) · Environmental Health Perspectives · doi:10.1289/ehp8314 · Cited by 16
Masson, J.-D., Angrand, L., Badran, G., de Miguel, R., & Crépeaux, G. (2022) · Critical Reviews in Toxicology · doi:10.1080/10408444.2022.2105688 · Cited by 17
“…studies in mice demonstrate inflammasome activation and IL1b production after ABAs inoculation as essential to induce efficient immune responses (Eisenbarth et al. 2008; Li et al. 2008; HogenEsch 2013), other studies have shown that NLRP3 or caspase-1 deficiency has no impact on antibody…”
BackgroundDynamics of redox signaling in aging via autophagy, inflammation, and senescence
Javali, P. S., Sekar, M., Kumar, A., & Thirumurugan, K. (2023) · Biogerontology · doi:10.1007/s10522-023-10040-3 · Cited by 18
Inflammasome et interleukine 1
Jéru, I., & Amselem, S. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2010.02.013 · Cited by 21
Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy
Baranyi, U., Farkas, A. M., Hock, K., Mahr, B., Linhart, B., Gattringer, M., Focke-Tejkl, M., Petersen, A., Wrba, F., Rülicke, T., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.028 · Cited by 17
Svensson, A., Sandberg, T., Siesjö, P., & Eriksson, H. (2017) · Immunologic Research · doi:10.1007/s12026-017-8972-5 · Cited by 19
“Activation of NLRP3-inflammasomes by ABAs initiates the cleavage and release of the pro-inflammatory cytokines IL-1β and IL-18 [2, 9, 10].”
Toxocariasis y vacunación para Toxocara: una revisión sistemática
Hernández, D. A. J., Salazar-Garcés, L. F., Baquero, M., Pinheiro, C. S., & Alcântara‐Neves, N. M. (2020) · Orinoquia · doi:10.22579/20112629.631 · Cited by 25
Rational design of innate defense regulator peptides as tumor vaccine adjuvants
Tian, Y., Hu, Q., Zhang, R., Zhou, B., Xie, D., Wang, Y., Zhang, X., & Yang, L. (2021) · npj Vaccines · doi:10.1038/s41541-021-00334-3 · Cited by 15
Initiation of type 2 immunity at barrier surfaces
McDaniel, M. M., Lara, H. I., & von Moltke, J. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2022.11.002 · Cited by 15
Tagé, B. S. S., Gonzatti, M. B., Vieira, R. P., Keller, A. C., Bortoluci, K. R., & Aimbire, F. (2024) · Inflammation · doi:10.1007/s10753-024-01983-x · Cited by 15
“There are many stimuli to induce neutrophilic asthma that activate NLRP3 [10], such as alum [14], complete Freund’s adjuvant (CFA) [15], and/or combined bacteria [16].”
Heydenreich, B., Bellinghausen, I., Lund, L., Henmar, H., Lund, G., Würtzen, P. A., & Saloga, J. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12294 · Cited by 17
The inflammasome and alum-mediated adjuvanticity
Kang, S., & Locksley, R. M. (2009) · F1000 Biology Reports · doi:10.3410/b1-15 · Cited by 17
Gene/environment interaction in the susceptibility of Crohn's disease patients to aluminum
Djouina, M., Waxin, C., Leprêtre, F., Tardivel, M., Tillement, O., Vasseur, F., Figeac, M., Bongiovanni, A., Sebda, S., Desreumaux, P., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.158017 · Cited by 17
Artificial Loading of ASC Specks with Cytosolic Antigens
Sahillioğlu, A. C., & Özören, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134912 · Cited by 17
“Alum, a widely used adjuvant in human vaccines, has been shown to exert its adjuvant activity via stimulation of NLRP3 inflammasome in an ASC dependent manner [15,16].”
BackgroundInflammasome Activity in Non-Microbial Lung Inflammation
Ather, J. L., Martin, R. A., Ckless, K., & Poynter, M. E. (2014) · Journal of Enviromental Immunology and Toxicology · doi:10.7178/jeit.20 · Cited by 17
Higuchi, K., Ziauddin, S. M., Yamashita, Y., Ozaki, Y., & Yoshimura, A. (2019) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2019.104625 · Cited by 15
Xu, H., Alzhrani, R. F., Warnken, Z. N., Thakkar, S. G., Zeng, M., Smyth, H. D. C., Williams, R. O., & Cui, Z. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00372 · Cited by 15
Potential use of inflammation and early immunological event biomarkers in assessing vaccine safety
Mastelic, B., Lewis, D. J., Golding, H., Gust, I. D., Sheets, R., & Lambert, P. (2012) · Biologicals · doi:10.1016/j.biologicals.2012.10.005 · Cited by 16
“Indeed, in some reports IgG1 antibodies seemed either essential [11,12] or dispensable [13e15], whereas IgE antibodies were shown to be dependent on NLRP3 [12,14].”
BackgroundSmith, W. J., Thompson, R., Egan, P. M., Zhang, Y., Indrawati, L., Skinner, J. M., Blue, J. T., & Winters, M. A. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.05.059 · Cited by 16
Siram, K., Lathrop, S. K., Abdelwahab, W., Tee, R. D., Davison, C. J., Partlow, H. A., Evans, J. T., & Burkhart, D. J. (2023) · Vaccines · doi:10.3390/vaccines12010021 · Cited by 17
The ASC inflammasome adapter governs SAA-derived protein aggregation in inflammatory amyloidosis
Losa, M., Emmenegger, M., Rossi, P. D., Schürch, P. M., Serdiuk, T., Pengo, N., Capron, D., Bieli, D., Bargenda, N., Rupp, N. J., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00107-0 · Cited by 15
“Al 3 + -containing adjuvants activate the NLRP3 in fl ammasome, but it is not known whether AgNO 3 stimulates ASC-dependent in fl ammasomes of innate immune cells (Eisenbarth et al, 2008), which would be a confounder in the current study.”
Opportunities and Challenges for Nanomaterials as Vaccine Adjuvants
Li, Z., Chen, P., Qu, A., Sun, M., Xu, L., Xu, C., Hu, S., & Kuang, H. (2025) · Small Methods · doi:10.1002/smtd.202402059 · Cited by 17
Allergic sensitization is enhanced in early life through toll‐like receptor 7 activation
Phipps, S., Hansbro, N. G., Lam, C., Foo, S. Y., Matthaei, K. I., & Foster, P. S. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03335.x · Cited by 15
SalmonellaPromotes ASC Oligomerization-dependent Caspase-1 Activation
Hwang, I., Park, S., Hong, S., Kim, E., & Yu, J. (2012) · Immune Network · doi:10.4110/in.2012.12.6.284 · Cited by 14
Adjuvant Immunotherapies as a Novel Approach to Bacterial Infections
Helbig, E. T., Opitz, B., & Sander, L. E. (2013) · Immunotherapy · doi:10.2217/imt.13.17 · Cited by 17
Domínguez-Martínez, D. A., Núñez-Avellaneda, D., Castañón‐Sánchez, C. A., & Salazar, M. I. (2018) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.17002327 · Cited by 16
Won, S., Hunt, K., Guak, H., Hasaj, B., Charland, N., Landry, N., Ward, B. J., & Krawczyk, C. M. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.10.099 · Cited by 16
Advances of functional nanomaterials for cancer immunotherapeutic applications
Hao, Y., Zhou, X., Li, R., Song, Z., & Min, Y. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1574 · Cited by 15
de Miguel, R., Asín, J., Rodríguez‐Largo, A., Molín, J., Echeverría, I., de Andrés, D., Pérez, M. M., Giral, I. D. B., Mold, M. J., Reina, R., et al. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110871 · Cited by 18
Maruyama, K., Cheng, J., Ishii, H., Takahashi, Y., Zangiacomi, V., Satoh, T., Hosono, T., & Yamaguchi, K. (2021) · Journal of Innate Immunity · doi:10.1159/000518953 · Cited by 16
Shakya, A. K., Kumar, A., Klaczkowska, D., Hultqvist, M. H., Hagenow, K., Holmdahl, R., & Nandakumar, K. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.034 · Cited by 14
“Recent studies have also shown that the commonly used adjuvant alum induced the release of IL-1 , IL-18, and IL-33(52,53) that is mediated by NALP3.(54) Hence, to check whether adjuvancy of PNiPAAm also involves the inflammasome pathway, we analyzed IL-1 levels in the sera from PNiPAAm-CII–immunized mice and compared…”
MethodSkin Barrier-Related Molecules and Pathophysiology of Asthma
Suzuki, Y., Kodama, M., & Asano, K. (2011) · Allergology International · doi:10.2332/allergolint.10-rai-0281 · Cited by 16
Nakayama, T., Kashiwagi, Y., Kawashima, H., Kumagai, T., Ishii, K. J., & Ihara, T. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.004 · Cited by 14
Kaba, S. A., Price, A. E., Zhou, Z., Sundaram, V., Schnake, P., Goldman, I. F., Lal, A. A., Udhayakumar, V., & Todd, C. W. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00164-08 · Cited by 15
Wang, B., Wang, X., Wen, Y., Fu, J., Wang, H., Ma, Z., Shi, Y., & Wang, B. (2015) · Scientific Reports · doi:10.1038/srep17695 · Cited by 16
Polymers in the Delivery of siRNA for the Treatment of Virus Infections
Reynolds, N. P., Dearnley, M., & Hinton, T. M. (2017) · Topics in Current Chemistry · doi:10.1007/s41061-017-0127-6 · Cited by 15
“Interestingly, common adjuvants including alum or aluminium salts appear to work through the same NLRP3 inflammasome pathway following disruption of the lysosomes after endocytosis [128, 132, 133].”
BackgroundMa, R., Zheng, H., Liu, Q., Wu, D., Li, W., Xu, S., Cai, X., & Li, R. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102037 · Cited by 14
Mast cells in innate and adaptive immunity to infection
Palker, T. J., Dong, G., & Leitner, W. W. (2009) · European Journal of Immunology · doi:10.1002/eji.200990325 · Cited by 14
Rhee, E. G., & Barouch, D. H. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03928.x · Cited by 14
Asín, J., Pascual‐Alonso, M., Pinczowski, P., Gimeno, M., Pérez, M. M., Muniesa, A., de Pablo-Maiso, L., Giral, I. D. B., Lacasta, D., Fernández, A., et al. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110934 · Cited by 14
Guo, X., & Dhodapkar, K. M. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.06.008 · Cited by 13
Metadata
- Authors
- Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A.
- Affiliations
- Yale University (US)
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Flavell, Richard A.
- Venue
- Nature
- Published
- 2008-05-21
- Volume
- 453
- Issue
- 7198
- Pages
- 1122-1126
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4804622
- OpenAlex
- W1979991507
- Cited by
- 1,542
- References
- 45
- Citations by year
- 2026: 34 · 2025: 43 · 2024: 54 · 2023: 56 · 2022: 52 · 2021: 81 · 2020: 62 · 2019: 53 · 2018: 74 · 2017: 81 · 2016: 91 · 2015: 85 · 2014: 91 · 2013: 125 · 2012: 132
- FWCI
- 57.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Bill and Melinda Gates Foundation
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Institute of Allergy and Infectious Diseases (K08AI065517)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NLRP3 inflammasome, aluminum hydroxide adjuvant, vaccine adjuvants, innate immunity, macrophages, IL-1β, IL-18, caspase-1, ASC, humoral antibody response, adaptive immune response, Toll-like receptors, complete Freund's adjuvant
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Adjuvants, Immunologic, Alum Compounds, Animals, Antibodies, Carrier Proteins, Cytoskeletal Proteins, Enzyme Activation, T-Lymphocytes, Helper-Inducer, Immunity, Innate, Inflammation, Macrophages, Mice, Inbred C57BL, Potassium, Cell Death, Caspase 1, Interleukin-18, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.